Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
Billy Tauzin Leaving PhRMA
Last week, Billy Tauzin, a 66-year-old cancer survivor, and former Congressman from Louisiana, announced that he would be…
GlaxoSmithKline’s CEO Andrew Witty and His Work in Developing Nations:…
The recent trend of media and Congress to call drug and pharmaceutical companies the “bad guys,” like Wall Street and AIG, only…
Extraordinary Measures: An Extraordinary Film
CBS Films this weekend releases “Extraordinary Measures,” a movie that tells the true story “of one man’s quest to find a cure…
JACO: Researchers Contributions and Ties with Industry
A recent study in the Journal of Oncology titled “Relationships Between Authorship Contributions and Authors’ Industry Financial…
Pfizer ‘s $3 Million CME Grant to Stanford University
According to a recent article in the New York Times, Stanford today will “announce plans to develop new continuing education…
New Models for Industry-Academic Partnerships
A recent article in the British Magazine titled “Drug Discovery Today,” calls for “the development of efficient models for…
Sales Reps in The Operating Room – There is Room and Need for Them
A recent article in the Washington Post described how company representatives for medical device companies are allowed to…
NY Times: All Generics Are Not Equal
A recent article in the New York Times highlighted a very interesting issue: why While the article starts out noting why generics…
International Society for Medical Publication Professionals – Good…
The International Society for Medical Publication Professionals (ISMPP) recently published a revised Good Publication Practice…
Health Care Reform: Kohl-Durbin Amendment Ban’s Data Mining
Last week, Senators Herb Kohl (D-WI) and Dick Durbin (D-IL) introduced an amendment to the Senate health care bill that would…